"Teaming Together To Extend Patients Lives We are a strategic Contract Research Organization (CRO) running multiple clinical trials in community oncology sites throughout the US. Uniquely focused on community-based hematology & oncology research sites, we provide real-world experience, data and outcomes that lead to improved clinical utility of cancer therapies, improving the lives of cancer patients"

During the past decade, Oncotherapeutics conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oncotherapeutics" are "Multiple Myeloma" (3 trials), "Breast Cancer" (1 trials), "Multiple Myeloma and Plasma Cell Neoplasm" (1 trials), "Refractory Plasma Cell Neoplasm" (1 trials) and "Stage II Multiple Myeloma" (1 trials). Many other conditions were trialed in "Oncotherapeutics" in a lesser frequency.

Most popular intervention types in "Oncotherapeutics" are "Drug" (5 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ascorbic acid" (2 trials), "melphalan" (2 trials), "PXD101" (1 trials), "Zoledronic acid" (1 trials) and "arsenic trioxide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncotherapeutics" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Oncotherapeutics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Oncotherapeutics, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Oncotherapeutics, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".